Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Menglin Xiao

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
CNS Neuroscience & Therapeutics|April 11, 2024
Deep-targeted gene sequencing reveals ARID1A mutation as an important driver of glioblastomaMenglin Xiao, Xiaoteng Cui, Can Xu, et al.
Frontiers in Immunology|January 24, 2022
PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in GlioblastomaKaikai Yi, Xiaoteng Cui, Xing Liu, et al.
Frontiers in Oncology|May 16, 2022
lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted TherapyCan Xu, Jixing Zhao, Jia Song, et al.
Neuro-Oncology|June 6, 2023
EPIC-0307-mediated selective disruption of PRADX-EZH2 interaction and enhancement of temozolomide sensitivity to glioblastoma via inhibiting DNA repair and MGMTLei Xin, Yanli Tan, Yuanxue Zhu, et al.
Theranostics|June 8, 2022
PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastomaEryan Yang, Lin Wang, Weili Jin, et al.
Cancer Communications (London, England)|November 3, 2023
Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastomaXiaoteng Cui, Jixing Zhao, Guanzhang Li, et al.
Neuro-Oncology|August 31, 2023
EPIC-1042 as a potent PTRF/Cavin1-caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastomaBiao Hong, Eryan Yang, Dongyuan Su, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
CNS Neuroscience & Therapeutics|April 11, 2024
Deep-targeted gene sequencing reveals ARID1A mutation as an important driver of glioblastomaMenglin Xiao, Xiaoteng Cui, Can Xu, et al.
Frontiers in Immunology|January 24, 2022
PTRF/Cavin-1 as a Novel RNA-Binding Protein Expedites the NF-κB/PD-L1 Axis by Stabilizing lncRNA NEAT1, Contributing to Tumorigenesis and Immune Evasion in GlioblastomaKaikai Yi, Xiaoteng Cui, Xing Liu, et al.
Frontiers in Oncology|May 16, 2022
lncRNA PRADX is a Mesenchymal Glioblastoma Biomarker for Cellular Metabolism Targeted TherapyCan Xu, Jixing Zhao, Jia Song, et al.
Neuro-Oncology|June 6, 2023
EPIC-0307-mediated selective disruption of PRADX-EZH2 interaction and enhancement of temozolomide sensitivity to glioblastoma via inhibiting DNA repair and MGMTLei Xin, Yanli Tan, Yuanxue Zhu, et al.
Theranostics|June 8, 2022
PTRF/Cavin-1 enhances chemo-resistance and promotes temozolomide efflux through extracellular vesicles in glioblastomaEryan Yang, Lin Wang, Weili Jin, et al.
Cancer Communications (London, England)|November 3, 2023
Blockage of EGFR/AKT and mevalonate pathways synergize the antitumor effect of temozolomide by reprogramming energy metabolism in glioblastomaXiaoteng Cui, Jixing Zhao, Guanzhang Li, et al.
Neuro-Oncology|August 31, 2023
EPIC-1042 as a potent PTRF/Cavin1-caveolin-1 interaction inhibitor to induce PARP1 autophagic degradation and suppress temozolomide efflux for glioblastomaBiao Hong, Eryan Yang, Dongyuan Su, et al.
Pageof 3